We explore how shippers can best use 3PLs and 4PLs to advance their drug supply chains.
Environmentally-sensitive biosimilars require a new approach for transport validation in controlled environment logistics network
Session topics include: safeguarding medicines on the move, blockchain, verifying packaging validation testing, GMP & GDP compliance.
Cathy Robertson examines the pharmaceutical industry's prospects in one of the most highly profiled emerging markets - Brazil.
At the 2018 Temperature Controlled Logistics event, the Senior Director of Global Supply Chain Quality at Genzyme Europe shared insight on reducing temperature excursions and the main challenges complicating these investigations.
Even though supply chain impatience rages in various industries, Keith Biondo isn't ready to push people out of the logistics equation just yet.
Pharmaceutical firms must be aware of their distribution network’s strengths and weaknesses so operations can be optimized and well equipped for any disruptions.
Whether your customer is the end consumer or B2B buyer, supply chain and customer service performance expectations are converging.
Despite its considerable outsourcing experience, pharma is still trying to find the perfect recipe for the selection stage as even the most rigorous selection process can fail to get things right first time round - with problems being flagged up 12-18 months after entering a partnership.
The term ‘networking’ has the power to strike fear into many pharma professionals. Despite that fact, many agree it would be a crucial career mistake to avoid networking.